Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

AEterna Zentaris presents promising in vivo data for AEZS-136

Sep. 12, 2012

Sanofi develops new 11-beta-HSD1 inhibitors for the treatment of diabetes

Sep. 10, 2012

FG-3019 safe and well tolerated in phase II study in IPF

Sep. 10, 2012

Phase II zabofloxacin results presented at ICAAC

Sep. 10, 2012

ILLUMINATE, SHINE and ENLIGHTEN study results presented

Sep. 7, 2012

Almirall presents phase III study results for aclidinium bromide in patients with COPD

Sep. 7, 2012

Results from three clinical studies reported for AZD-5069

Sep. 7, 2012

Targacept presents results for its nicotinic acetylcholine receptor agonists

Sep. 7, 2012

Study evaluates dose-response of umeclidinium in COPD

Sep. 6, 2012

New lysophospholipid S1P1 receptor agonists presented at ACS meeting

Sep. 6, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 21, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
LIT-002 is strong candidate for autism and neuropathic pain
BioWorld Science
Researchers from the University of Strasbourg and the Centre National de la Recherche Scientifique (CNRS) have presented data on LIT-002, a nonpeptide oxytocin...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
New biomarker may improve RSV drug screening
BioWorld
Respiratory syncytial virus (RSV) infection is responsible for 3.2 million hospital admissions and about 118,000 deaths in children under 5 years of age. The...